share_log

Benchmark Reiterates Speculative Buy on HeartBeam, Maintains $8 Price Target

Benzinga ·  Nov 16, 2023 12:16

Benchmark analyst Bill Sutherland reiterates HeartBeam (NASDAQ:BEAT) with a Speculative Buy and maintains $8 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment